Trxade Group (MEDS)
NASDAQ:MEDS
Holding MEDS?
Track your performance easily

Trxade Group (MEDS) Income Statement

150 Followers

Trxade Group Income Statement

Last quarter (Q2 2024), Trxade Group's total revenue was $18.70K, a decrease of -99.17% from the same quarter last year. In Q2, Trxade Group's net income was $-1.83M. See Trxade Group’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 3.79M$ 8.27M$ 11.45M$ 9.89M$ 17.12M$ 7.44M
Cost of Revenue
$ 4.40M$ 5.67M$ 6.00M$ 5.14M$ 11.42M$ 2.57M
Gross Profit
$ -604.25K$ 2.60M$ 5.45M$ 4.75M$ 5.71M$ 4.87M
Operating Expense
$ 12.96M$ 9.86M$ 9.88M$ 9.34M$ 7.49M$ 4.38M
Operating Income
$ -13.56M$ -7.26M$ -4.42M$ -4.59M$ -1.78M$ 493.74K
Net Non Operating Interest Income Expense
$ -945.59K$ -1.19M$ -336.21K$ -23.59K$ -29.39K$ -53.23K
Other Income Expense
$ -690.45K$ -5.26M$ -58.13K$ -247.86K$ -725.97K$ -724.95K
Pretax Income
$ -17.24M$ -13.72M$ 162.34K$ -5.32M$ -2.54M$ -284.43K
Tax Provision
------
Earnings From Equity Interest Net Of Tax
$ -12.67M-----
Net Income Common Stockholders
$ 5.01M$ -17.84M$ -925.19K$ -5.32M$ -2.54M$ -284.43K
Basic EPS
$ 0.87$ -23.35$ -0.41$ -0.65$ -0.33$ -0.05
Diluted EPS
$ 24.00$ -7.49$ -0.41$ -0.65$ -0.33$ -0.05
Basic Average Shares
$ 4.15M$ 764.06K$ 8.47M$ 8.14M$ 7.71M$ 5.93M
Diluted Average Shares
$ 10.85M$ 2.38M$ 8.47M$ 8.14M$ 7.71M$ 5.93M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 17.35M$ 15.54M$ 15.87M$ 14.48M$ 18.90M$ 6.94M
Net Income From Continuing And Discontinued Operation
$ 4.22M$ -17.84M$ -925.19K$ -5.32M$ -2.54M$ -284.43K
Normalized Income
$ -8.91M$ -2.00M$ 2.29M-$ -1.81M$ 512.59K
Interest Expense
----$ 29.39K$ 53.23K
EBIT
$ -16.18M$ -12.52M$ 498.55K$ -5.29M$ -2.51M$ -231.20K
EBITDA
$ -15.22M$ -11.47M$ 694.40K$ -5.15M$ -2.40M$ -136.47K
Currency in USD

Trxade Group Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis